iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of
advanced image analysis, workflow solutions and radiation therapies for
the early identification and treatment of cancer, today announced that
the Company will release financial results for the three and 12 months
ended December 31, 2013, following the close of the market on Wednesday,
February 19, 2014.
Ken Ferry, President and Chief Executive Officer, and Kevin Burns, Chief
Financial and Operating Officer, will host a conference call for
investors beginning at 8:00 a.m. ET on Thursday, February 20, 2014, to
discuss the 2013 fourth quarter and full year financial results and to
answer questions.
Shareholders and other interested parties may participate in the
conference call by dialing 888-713-4211 (domestic) or 617-213-4864
(international) and entering passcode 49351643. The call also will be
broadcast live on the Internet at www.streetevents.com
and www.icadmed.com.
A replay of the conference call will be accessible two hours after its
completion through February 26, 2014 by dialing 888-286-8010 (domestic)
or 617-801-6888 (international) and entering passcode 83837249. The call
will also be archived for 90 days at www.streetevents.com
and www.icadmed.com.
About iCAD, Inc.
iCAD is an industry-leading provider of
advanced image analysis, workflow solutions and radiation therapies for
the early identification and treatment of common cancers. iCAD offers a
comprehensive range of high-performance, upgradeable CAD solutions for
mammography and advanced image analysis and workflow solutions for
Magnetic Resonance Imaging, for breast and prostate cancers and Computed
Tomography for colorectal cancer. iCAD’s Xoft System, offers radiation
treatment for early-stage breast cancer that can be administered in the
form of intraoperative radiation therapy or accelerated partial breast
irradiation. The Xoft System is also cleared for the treatment of
non-melanoma skin cancer and endometrial cancer. For more information,
call 877-iCADnow, or visit www.icadmed.com.
"Safe Harbor" Statement under the Private Securities Litigation
Reform Act of 1995
Certain statements contained in this News
Release constitute “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve a number of known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of the Company to be materially different
from any future results, performance or achievements expressed or
implied by such forward-looking statements. Such factors include, but
are not limited to, the Company’s ability to defend itself in litigation
matters, the risks relating to the Company’s acquisition of Xoft
including, the expected benefits of the acquisition may not be achieved
in a timely manner, or at all; the Xoft business operations may not be
successfully integrated with iCAD’s and iCAD may be unable to achieve
the expected synergies, business and strategic objectives following the
transaction, the risks of uncertainty of patent protection; the impact
of supply and manufacturing constraints or difficulties; product market
acceptance; possible technological obsolescence; increased competition;
customer concentration; and other risks detailed in the Company’s
filings with the Securities and Exchange Commission. The words
“believe”, “demonstrate”, “intend”, “expect”, “estimate”, “will”,
“continue”, “anticipate”, “likely”, and similar expressions identify
forward-looking statements. Readers are cautioned not to place undue
reliance on those forward-looking statements, which speak only as of the
date the statement was made. The Company is under no obligation to
provide any updates to any information contained in this release. For
additional disclosure regarding these and other risks faced by iCAD,
please see the disclosure contained in our public filings with the
Securities and Exchange Commission, available on the Investors section
of our website at http://www.icadmed.com
and on the SEC’s website at http://www.sec.gov.
Copyright Business Wire 2014